Cited by 626Viral Infections and Immunology ResearchMechanical Circulatory Support DevicesTakotsubo Cardiomyopathy and Associated Phenomena

The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.

Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association

Open access

Kociol, Robb D., Cooper, Leslie T., Fang, James C., Moslehi, Javid J., Pang, Peter S., Sabe, Marwa A., Shah, Ravi V., Sims, Daniel B., Thiene, Gaetano, Vardeny, Orly, On behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology·2020·Circulation

DOI 10.1161/cir.0000000000000745

Open this paper in CoChat — free account Open PDF

Abstract

Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe diffuse cardiac inflammation often leading to death resulting from cardiogenic shock, ventricular arrhythmias, or multiorgan system failure. Historically, FM was almost exclusively diagnosed at autopsy. By definition, all patients with FM will need some form of inotropic or mechanical circulatory support to maintain end-organ perfusion until transplantation or recovery. Specific subtypes of FM may respond to immunomodulatory therapy in addition to guideline-directed medical care. Despite the increasing availability of circulatory support, orthotopic heart transplantation, and disease-specific treatments, patients with FM experience significant morbidity and mortality as a result of a delay in diagnosis and initiation of circulatory support and lack of appropriately trained specialists to manage the condition. This scientific statement outlines the resources necessary to manage the spectrum of FM, including extracorporeal life support, percutaneous and durable ventricular assist devices, transplantation capabilities, and specialists in advanced heart failure, cardiothoracic surgery, cardiac pathology, immunology, and infectious disease. Education of frontline providers who are most likely to encounter FM first is essential to increase timely access to appropriately resourced facilities, to prevent multiorgan system failure, and to tailor disease-specific therapy as early as possible in the disease process.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000000745

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Brahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6385 · Cited by 3,713
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Self-citation
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Friedrich, M. G., Sechtem, U. P., Schulz‐Menger, J., Holmvang, G., Alakija, P., Cooper, L. T., White, J. A., Abdel‐Aty, H., Gutberlet, M., Prasad, S. K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.007 · Cited by 2,523
Self-citation
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Self-citation
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.072 · Cited by 2,059
Self-citation
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
van Diepen, S., Katz, J. N., Albert, N. M., Henry, T. D., Jacobs, A. K., Kapur, N. K., Kılıç, A., Menon, V., Ohman, E. M., Sweitzer, N. K., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000525 · Cited by 1,936
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608
Self-citation

Show all 199 references

Research works printed but not linked: 2

10.1161/CIRCHEARTFAILURE.112.000087 · DOI
10.1007/s10741-012-9358-3 · DOI · Paper page

Sorted by citations

Items 401–500 of 626

A case of destination therapy for post-fulminant myocarditis with myelodysplastic syndrome
Nakamura, M., Imamura, T., Hida, Y., Izumida, T., Nakagaito, M., Nagura, S., Doi, T., Fukahara, K., & Kinugawa, K. (2024) · Journal of Artificial Organs · doi:10.1007/s10047-024-01455-x · Cited by 2
Myocarditis and Inflammatory Cardiomyopathy
Kim, Y., & Dudzinski, D. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-45792-1_27 · Cited by 2
Inflammatory Cardiomyopathy: Case-based Review on Clinical Presentation, Diagnosis, and Management
Li, B., Lento, P. A., & Pan, S. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000369 · Cited by 2
Multimodality diagnosis of cardiac involvement in COVID-19 patients
Balinisteanu, A., Memis, H., Postulache-Cosmulescu, G., Mihalcea, D. J., Mihaila, S. B., & Vinereanu, D. (2021) · Romanian Journal of Cardiology · doi:10.47803/rjc.2021.31.1.17 · Cited by 2
Recovery of a critically ill patient with COVID-19 myocarditis
Boylan, M., Roddy, J., Lim, N., Morgan, R. K., McAdam, B. F., & Kiernan, F. M. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02681-5 · Cited by 3
Infección por SARS-CoV-2 y miocarditis
Forero-Saldarriaga, S., Puerta-Rojas, J. D., Estupiñán-Paredes, R. N., Coy-Pedraza, L. C., Moreno, N. L., & Castellanos-Parada, J. (2022) · Medicina y Laboratorio · doi:10.36384/01232576.558 · Cited by 2
Myocardial Injury and Altered Gene Expression Associated with SARS-CoV-2 Infection or mRNA VaccinationPreprint
Altman, N. L., Berning, A. A., Saxon, C. E., Adamek, K. E., Wagner, J. A., Slavov, D. B., Quaife, R. A., Gill, E. A., Minobe, W. A., Jonas, E. R., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4137991 · Cited by 2
New insights into the management of fulminant myocarditis
Cooper, L. T. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf866 · Cited by 3
Self-citation
Distribution, management and outcomes of AMI according to principal diagnosis priority during inpatient admission
Matetić, A., Doolub, G., Spall, H. G. C. V., Alkhouli, M. A., Quan, H., Butalia, S., Myint, P. K., Bagur, R., Pana, T. A., Mohamed, M., et al. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14554 · Cited by 1
Giant Cell Myocarditis in Children: Elusive Giant Cells Might Not Be the Only Clue
Carreon, C. K., Hagel, J. A., Daly, K. P., & Pérez‐Atayde, A. R. (2021) · Pediatric and Developmental Pathology · doi:10.1177/10935266211044952 · Cited by 1
Acute Myocarditis Caused by Francisella tularensis: a Case Report
Bäck, A. T., Flygare, C., Eriksson, A., & Johansson, A. F. (2023) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-023-01436-w · Cited by 1
Myocarditis associated with immune checkpoint inhibitor therapies: diagnostic and treatment strategies
Баллюзек, М. Ф., Проценко, С., & Потиевская, В. (2023) · Voprosy Onkologii · doi:10.37469/0507-3758-2023-69-2-219-226 · Cited by 1
Development and Validation of a Prediction Model on Adult Emergency Department Patients for Early Identification of Fulminant Myocarditis
Jiang, M., Ke, J., Fang, M., Huang, S., & Li, Y. (2023) · Current Medical Science · doi:10.1007/s11596-023-2768-8 · Cited by 1
A multidisciplinary approach of a patient with pheochromocytoma presenting as recurrent acute fulminant myocarditis: A rare case report and comprehensive review of literature
Martha, J. W., Prameswari, H. S., Munita, F. F., Kusumawardhani, N. Y., Hasan, M., Astuti, A., Soetedjo, N. N. M., Agustina, H., & Sari, M. T. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102521 · Cited by 1
Dramatic Improvement of Acute Fulminant Lymphocytic Myocarditis with Short-course Intravenous Pulse Corticosteroids: A Case Study
Elasfar, A., Suliman, S., Hijji, M. A. A., Badr, A. M. H., Al‐Bozom, I., & Patel, A. A. A. H. (2024) · Heart Views · doi:10.4103/heartviews.heartviews_134_23 · Cited by 1
Acute Left Ventricular Systolic Heart Failure
Flores, S., Loomba, R. S., & Bronicki, R. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-63557-1_8 · Cited by 1
Machine learning-based mortality prediction for pediatric fulminant myocarditis using cytokine profiles
Jing, S., Suzuki, T., Suzuki, K. T., Nomura, Y., Kunida, K., Sakumura, Y., Uchida, H., Saito, K., Ito, R., Kito, M., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-50260-4 · Cited by 1
Fulminant Myocarditis With Normal Inflammatory Markers
Nirthanakumaran, D., Pathan, S., Parikh, D. S., & Pathan, F. K. (2025) · JACC Case Reports · doi:10.1016/j.jaccas.2025.103878 · Cited by 1
Fibrinogen-to-albumin ratio as a novel biomarker for risk assessment in clinically suspected acute myocarditis
Levi-Gofman, L., Atar, S., & Moady, G. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101791 · Cited by 1
Eosinophilic myocarditis: case series and review of the literature
Laiso, L. E., Bocchino, P. P., Angelini, F., LIO, G. D., Gallone, G., Gravinese, C., Frea, S., Pidello, S., Raineri, C., & Ferrari, G. M. D. (2025) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.25.06829-2 · Cited by 1
From infection to intervention: post-acute sequelae of SARS-CoV-2 infection and cardiovascular risk
Wasim, R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-02006-3 · Cited by 1
Circulating microRNAs in viral myocarditis: Advancements in biological understanding and potential clinical applications
Ma, M.-R., Song, X., Wang, X.-K., Liu, Y., Cai, X., Zheng, R.-R., Liu, M., Ma, L., Wang, F., & Ma, L. (2025) · Gene · doi:10.1016/j.gene.2025.149866 · Cited by 2
“Bridging the clinical, molecular and genetic perspectives on myocarditis in post-COVID-19 era”
Birla, S., Angural, A., Madathumchalil, A., Shende, R. V., Shastry, S. V., Shekar, P. K., Mahadevappa, M., Vishwanath, P. M., & Prashant, A. (2026) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2026.200576 · Cited by 1
Современные аспекты острого миокардита у детей: обзор литературы
Строгая, Н. В., Романова, О. Н., Batyan, G. M., & Строгий, В. В. (2025) · Клиническая инфектология и паразитология · doi:10.34883/pi.2025.14.4.040 · Cited by 1
A case series and literature review of immune checkpoint inhibitors-associated myocarditis (ICIM) in non-small cell lung cancer
Sun, Y., Liu, Y., Wang, Y., Dai, X., Lin, S., Bi, J., Zhang, J., Song, Y., Jiang, J., & Chen, S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1615085 · Cited by 1
Serum Interleukin-6 and Ventricular Tachycardia as Predictors of Mortality in Children With Fulminant Myocarditis
Zhang, Y.-L., Zhao, S., Qian, C.-P., & Xc, H. (2026) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.08.018 · Cited by 1
Clinical Outcomes of Venoarterial Extracorporeal Membrane Oxygenation in Acute and Critical Cardiac Illnesses: A Single-Center Experience
Yuan, X., Yao, C., Wang, H., & Shao, M. (2026) · Cardiology · doi:10.1159/000550447 · Cited by 1
Short-Term Outcomes in Influenza Virus-Related Myocarditis: A Single-Centre Real-Life Experience
Birtolo, L. I., Lattanzio, A., Myftari, V., Pietro, G. D., Manzi, G., Lovero, B. F., Pugliese, M., Caputo, A., Scoccia, G., Zingaropoli, M. A., et al. (2026) · Cardiovascular Medicine · doi:10.3390/cardiovascmed29010007 · Cited by 1
Short-Term Outcomes of Intra-Aortic Balloon Pump vs. Microaxial Flow Pump for Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation
Iikura, S., Ikeda, Y., NAKAHARA, S., Watanabe, Y. S., Haruki, Y., Takigami, Y., Eda, Y., Iida, Y., Nabeta, T., Ishii, S., et al. (2026) · Circulation Reports · doi:10.1253/circrep.cr-25-0283 · Cited by 2
Prognostic value of QRS duration in acute myocarditis: insights from a multicentre cohort study
Son, J., Kim, J., Hong, D., Hyun, J., Park, H., Kim, I., Kim, M. N., Kim, K., Lee, S., & Yang, J. H. (2026) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuag050 · Cited by 1
Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of the ESC Working Group on Myocardial & Pericardial Diseases
Kuchynka, P., Brucato, A. L., Tschöpe, C., Cameli, M., Castelleti, S., Cooper, L. T., Dweck, M. R., Frustaci, A., Heidecker, B., Klingel, K., et al. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag043 · Cited by 1
Self-citation
Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations
Mincu, R. I., Zimmer, L., Vlachopoulou, D., Haj‐Yehia, E., Hoffmann, J., Michel, L., Livingstone, E., Schadendorf, D., Tasdogan, A., Totzeck, M., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70536 · Cited by 1
Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-associated myocarditis (2026 edition)
Yan, W., Qingqing, C., Yuan, L., Jiahui, C., Hao, L., Jinyi, L., Zhiming, W., Yinman, W., Zhifeng, Y., Shilong, Z., et al. (2026) · Clinical Cancer Bulletin · doi:10.1007/s44272-026-00065-3 · Cited by 1
Post-viral myocarditis
Sokolski, M., Zychla, W., Wilk, M., Balcer, B., Jakubasz, P., Sokolska, J. M., Guidetti, F., Krupa‐Zabiegała, J., Chick, W., & Bromage, D. I. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10654-y · Cited by 1
MicroRNAs as diagnostic and prognostic biomarkers for viral myocarditis: A systematic review and meta-analysis
Holst, M. A. M., Navarro, F. A. S., & León-Pedroza, J. I. (2026) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2026.101975 · Cited by 1
When Myocardial Injury in Lupus Is Not Lupus: Probable Antimalarial‐Associated Cardiomyopathy Mimicking Lupus Myocarditis
Covo, D. A. P., Beltrán, M. C. B., Gómez, D. A. O., Bueno, C. O. P., Juan-Guardela, E. J. J., Franco, C. H. C., Andres, C. M. E., Omaña-Álvarez, L., Mariño, A., & Peña, Á. A. G. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73413 · Cited by 1
Global, Regional, and National Burden of Myocarditis and Its Impairment, 1990-2023
Lee, S., Lee, H., Kim, M. S., Rad, E. M., Johnson, C. O., Lara-Castor, L., Aalruz, H., Abate, Y. H., Abbas, N., Abbastabar, H., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.07.039 · Cited by 2
Diagnosis and Treatment of Fulminant Myocarditis
Masoudi, F. A., Msph, Facc, & Faha (2020) · Journal watch · doi:10.1056/nejm-jw.na50851 · Cited by 1
Multiple-organ failure as a result of non-COVID-19 coronavirus infection
Álvarez, J. L., Castillo, J. Q., Quevedo, O. P., García, J. R., González, C., & Lorenzo-Villegas, D. L. (2021) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2021.eng.e252 · Cited by 1
Fulminant myocarditis and acute heart failure in the light of new American Heart Association 2020 guidelines. Mechanical cardiac support and endomyocardial biopsy. What should be first?
Płonka, J., Gawda, R., Sacha, J., Bugajski, J., Brzostowicz, T., Molsa, M., Czarnik, T., Klingel, K., & Gierlotka, M. J. (2022) · Cardiology Journal · doi:10.5603/cj.a2022.0052 · Cited by 1
A Stormy Heart
Kratka, A., Tedrow, U. B., Mitchell, R. N., Miller, A. L., & Loscalzo, J. (2023) · New England Journal of Medicine · doi:10.1056/nejmcps2116690 · Cited by 1
A teenager with adenoviral myocarditis mimicking hypertrophic cardiomyopathy
Aydin, A., Ali, F., Khariton, M., & Spencer, R. (2023) · Cardiology in the Young · doi:10.1017/s1047951123000975 · Cited by 1
Adenosine-sensitive incessant right ventricular outflow tract ventricular tachycardia complicating fulminant lymphocytic myocarditis: Case report
Coello, R. A., Kulchetscki, R. M., Chokr, M. O., de Melo, S. L., Pisani, C. F., & Scanavacca, M. (2023) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2023.10.032 · Cited by 1
Rare presentation of COVID-19 vaccine-induced myocarditis: A case report
Rehman, M. A. U., Ilyas, H., Iqbal, J., Huda, S. H., Akram, H., Mohamed, S., & Kuwari, M. A. (2023) · Journal of emergency medicine, trauma & acute care · doi:10.5339/jemtac.2023.35 · Cited by 1
Patological changes in cardiovascular system among the patients with post-COVID-19 syndrome
Akimochkin, G. S., Volgograd, R. F., Matokhin, S. E., Skvortsov, V. V., Skvortsova, E. M., & Saraev, S. S. (2023) · Therapist’s Bulletin · doi:10.31550/2712-8601-vt-2023-5-6-2 · Cited by 1
Rationale and design of the French cohort of acute myocarditis diagnosed by cardiac magnetic resonance imaging (MyocarditIRM)
Bouleti, C., Servoz, C., Alos, B., Ehmer, C., Jacquier, A., Ternacle, J., Deux, J., Tea, V., Mousseaux, É., Garcia, R., et al. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.04.002 · Cited by 1
Viral cardiovascular surgical diseases: global burdens, challenges and opportunities
Gomes, Z., Lee, G. S., Mesfin, S., Rocha, R. V., & Vervoort, D. (2024) · Future Cardiology · doi:10.1080/14796678.2024.2348382 · Cited by 1
Assessment of myocardial injury by SPECT myocardial perfusion imaging in patients with COVID-19 infection in a single center after lifting the restrictions in China
Xin, K., Ma, X., Meng, X., Zhang, X., Yang, W., Ma, T., Zhou, C., Wang, J., & Li, G. (2024) · Annals of Nuclear Medicine · doi:10.1007/s12149-024-01970-0 · Cited by 1
Post-Vaccine Myocarditis: Clinical Insights and Epidemiological Trends
Vani, N. M. S. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24sep1097 · Cited by 1
Reviewing the current diagnostic and treatment approaches for myocarditis – analysis of literature
Zys, D., Wojszczyk, M., Ryniecka, J., Czyż, W., Kacperczyk, J., Chuncia-Ileczko, M., Wójcikiewicz, M., Arczewski, F., Dziedzic, K., & Kulbacka, J. (2025) · Quality in Sport · doi:10.12775/qs.2025.37.57145 · Cited by 1
Giant Cell Myocarditis: Navigating Diagnosis and Management of a Mysterious Entity
Mortada, I., Mhanna, M., Eschbacher, K. L., & Mansour, S. (2025) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2025.02.035 · Cited by 1
Long-term left ventricular ejection function in fulminant and non-fulminant myocarditis: A multicenter study in China
Li, G., Zhang, J., Xu, Z., Ning, Y., Zhang, L., Yang, J., Chen, G., Li, F., & Jiang, J. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101738 · Cited by 1
Deteksi dan Penanganan Awal Miokarditis dan Miokarditis Fulminan
Nauli, S. E., & Prameswari, H. S. (2020) · Indonesian Journal of Cardiology · doi:10.30701/ijc.v1i1.995 · Cited by 1
Differential Diagnosis of Myocardial Injury in the SARS-CoV-2 Era – Myocarditis Versus Acute Coronary Syndrome
Ţolescu, C., Gerculy, R., Libenciuc, C., & Kovács, I. (2020) · Journal of Cardiovascular Emergencies · doi:10.2478/jce-2020-0013 · Cited by 1
The Diagnostic and Etiologic Challenge of Myocarditis in Oncologic Patients: Acute Myocarditis During Induction Treatment with All-Trans Retinoic Acid
Coma, N., Moral, S., Coll, R., Moret, C., Albert, X., & Brugada, R. (2021) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2021.101.106 · Cited by 1
Fatal lymphocytic myocarditis masquerading as thoracic aortic dissection
Henry, E. S. (2021) · Case Reports in Acute Medicine · doi:10.1159/000517481 · Cited by 1
The Pathological Features of CoViD19 Cardiovascular Complications
Mallick, U. (2022) · Springer eBooks · doi:10.1007/978-3-030-90065-6_4 · Cited by 1
Treatment of myocarditis in COVID-19 patients
Trofimov, N. A., Babokin, V. E., Egorov, D. V., Dubova, A. V., Nikolsky, A. V., Табаев, Р. Г., Rodionov, A. L., Dragunov, A. G., Nikolaeva, O. V., & Жамлиханова, С. С. (2022) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio202215021159 · Cited by 1
Acute myocarditis masquerading as anterior wall myocardial infarction: A case report
Vohra, S., Yadav, A., Sharma, P., Khan, S., & Jaiswal, V. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104884 · Cited by 1
Atypical infiltrates on endomyocardial biopsy are associated with adverse outcomes in pediatric heart transplantation
Hope, K. D., Morris, S. A., Kearney, D. L., Puri, K., Choudhry, S., Spinner, J. A., Tunuguntla, H. P., Price, J. F., Dreyer, W. J., Nicholas, S. K., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.06.007 · Cited by 1
Fulminant Lymphocytic Myocarditis Successfully Managed with Intra-Aortic Balloon Pump and Extracorporeal Membrane Oxygenation: A Case Report
Araujo, S. D. S., Brigo, I. R., Angerami, L. F. M. C., de Brito, P. H. F., Filho, R. B. R., Terra, T. M. S., Teixeira, T. B., de Assis, A. C. R., Soares, P. R., & Scudeler, T. L. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.941422 · Cited by 1
A case report of giant cell myocarditis complicated by severe heart failure: the value of early endomyocardial biopsy and mechanical circulatory support
Lunde, T., Gude, E., Myrmel, G. M. S., Haaverstad, R., & Saeed, S. (2023) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-23-265 · Cited by 1
“Hook”ing the diagnosis: Cardiac magnetic resonance imaging remains only one piece of the puzzle in diagnosing giant cell versus sarcoidosis related myocarditis
Czum, J. M., & Gilotra, N. A. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131293 · Cited by 1
Commentary: Myocarditis, Shock, and Extracorporeal Life Support, a Significant Story Revealing the Unexpected
Shirafkan, A., Gidea, C., & Stein, L. H. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.09.030 · Cited by 1
Reply to: Comments on “Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics”
Mitsuboshi, S., Hamano, H., & Zamami, Y. (2023) · International Journal of Cancer · doi:10.1002/ijc.34767 · Cited by 1
Circulating Synthetic SARS-CoV-2 Spike Proteins Possibly Contribute to a Transient ACE2 Dysfunction Leading to Rare Cases of Myocarditis after COVID-19 mRNA VaccinationPreprint
Devaux, C. A., Colson, P., Raoult, D., & Camoin‐Jau, L. (2023) · Preprints.org · doi:10.20944/preprints202311.1883.v1
Future Perspectiv erspectives in Acute My es in Acute Myocarditis Complicated by Cardiogenic Shock
Tavecchia, G., Cartella, I., & Ammirati, E. (2022) · Journal of shock & hemodynamics · doi:10.57905/josh/e2022123 · Cited by 1
Spatial transcriptomics reveals layered immune-metabolic architecture of giant cell myocarditisPreprint
Musigk, N., Sudy, A., Suwalski, P., Jechow, K., Liebig, J., Bischoff, P., Just, I. A., Falk, V., Schoenrath, F., Eils, R., et al. (2025) · medRxiv · doi:10.64898/2025.12.15.25342188 · Cited by 1
Myocarditis and pericardial syndromes
Boffa, G., & Ceconi, C. (2019) · doi:10.1093/med/9780198759935.003.0017_update_001
Clinical characteristics and treatment effects of astragalus injection in non-pediatric patients with acute fulminant myocarditis
Yang, H., Lu, Y., Yang, H., & Yuan, J. (2020) · Medicine · doi:10.1097/md.0000000000023062
Acute Myocarditis Associated with Coronavirus Disease 2019: Systematic Review and Pooled Analysis of Reported Cases
Burgos, L. M., Ramírez, A. G., & Díez, M. (2020) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_88_20
Neurologic complications of myocarditis
Block, H. S. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819814-8.00030-5
Nowo wykryta arytmia komorowa u ozdrowieńca po chorobie koronawirusowej 2019
Sawościan, M., Szulc-Bagrowska, J., Wójcik, I., & Lelonek, M. (2021) · Folia Cardiologica · doi:10.5603/fc.2021.0009
COVID-19 Myocarditis
Kwon, S., Alter, E. L., Bangalore, S., & Nolan, A. (2021) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001016
Mechanical Circulatory Support for Myocarditis Complicated by Cardiogenic Shock
Jankuvienė, A., Ščupakova, N., Urbonas, K., Mikelevič, L., Drutel, R., & Samalavicius, R. S. (2021) · Lietuvos chirurgija · doi:10.15388/lietchirur.2021.20.41
Clinical Outcome and Risk Factors for Acute Fulminant Myocarditis Supported by Venoarterial Extracorporeal Membrane Oxygenation: an Analysis of Nationwide CSECLS Database in China MainlandPreprint
Hao, T., Jiang, Y., Wu, C., Li, C., Chen, C., Xie, J., Pan, C., Guo, F., Huang, Y., Liu, L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-739094/v1
Acute myocardial injury in COVID-19 survivors without cardiovascular history
Sabanova, V. D., Davydkin, I. L., Zolotovskaya, I. A., Gimatdinova, G. R., & Терешина, О. В. (2021) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202124071111
Reply to “The SARS-COV Pandemic Does Not Absolve From Solid Medical Trade”
Okor, I., Bob‐Manuel, T., & Krim, S. R. (2021) · Ochsner Journal · doi:10.31486/toj.21.5021
Cardiovascular Magnetic Resonance Imaging of COVID-19 Myocarditis
Chopra, R., & Kumar, P. (2021) · Cardiovascular Imaging Asia · doi:10.22468/cvia.2021.00220
PECULIARITIES OF CHANGES IN CARDIOHEMODYNAMICS AND ELECTRICAL ACTIVITY OF THE HEART IN ACUTE MYOCARDITIS ASSOCIATED WITH CORONAVIRUS INFECTION (COVID-19)
Чекаліна, Н. І., Kazakov, Y. M., Борисова, З. О., Ivashuta, I. M., & Kirusha, I. S. (2021) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2021-3-161-158-162
Síndrome de Stokes-Adams como debut de una miocarditis fulminante: presentación de un caso exitoso
Medina, N. R., Espinosa, R. E. M., Cruz, C. A. J., & Garzón, R. G. C. (2021) · Universitas Médica · doi:10.11144/javeriana.umed62-3.stok
Early application of extracorporeal membrane oxygenation for myocarditis with shock: a case report
Meng, H., Ruan, J., Wang, X., Shi, K., Li, X., Liu, G., Meng, F., & Yang, P. C. (2021) · Journal of International Medical Research · doi:10.1177/03000605211058875
Additional Heart Failure Topics
Hanna, E. B. (2022) · doi:10.1002/9781119832737.ch5
Infection: Myocarditis
Ismail, T. F., Hua, A. X., Haaf, P., & Giorgetti, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-81131-0_7 · Cited by 1
Progress in Diagnosis and Treatment of Fulminant Myocarditis
徐, 婷. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.123320
Eosinophilic Myocarditis: When Allergies Attack the Heart!
Jain, V., Bansal, A., Aggarwal, D., Chetrit, M., Gupta, M., Bhatia, K., Thakkar, S. J., Doshi, R. P., Ghosh, R. K., Bandopadhyay, D., et al. (2021) · Cardiology in Review · doi:10.1097/crd.0000000000000373
Management
Bona, R. D., Pescetelli, F., & Valbusa, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-94992-1_15
In-Hospital Cardiac Manifestations of COVID-19 Pneumonia and their Management
Nadakinamani, R. G., Panduranga, P., Aziz, K. M., James, P., & Youssef, H. B. (2022) · International Journal of Clinical Cardiology · doi:10.23937/2378-2951/1410260
Features of myocardial damage at COVID-19
Hamidov, S. H., Обрезан, А. Г., Lobanova, P. S., & Azarenko, S. V. (2022) · Eurasian heart journal · doi:10.38109/2225-1685-2022-3-66-72
Fulminant Lymphocytic Myocarditis Secondary to Coxsackie a Virus With Full Myocardial Recovery Following Venoarterial Extracorporeal Membrane Oxygenation
Hou, L., Jnani, J., Patel, P., Bhinder, J., Boutis, L., Lee, A., & Grayver, E. (2022) · Future Cardiology · doi:10.2217/fca-2022-0078
Temporary mechanical support in acute fulminant myocarditis: We need to know more
Bottiroli, M., Moroni, F., & Tavazzi, G. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.11.054
Balancing treatment of COVID-19 with diabetes
Chen, F. (2022) · International Conference on Biomedical and Intelligent Systems (IC-BIS) · doi:10.1117/12.2660059
Diagnosis and Differential Diagnosis of Fulminant Myocarditis
Hang, W., & Wang, D. W. (2022) · Springer eBooks · doi:10.1007/978-981-19-5759-8_13
Etiology and Pathogenesis of Fulminant Myocarditis
Chen, C., & Wang, D. W. (2022) · Springer eBooks · doi:10.1007/978-981-19-5759-8_4
Rehabilitation Treatment for Myocarditis
Jiang, J. (2022) · Springer eBooks · doi:10.1007/978-981-19-5759-8_18
Introduction: Accumulating More Knowledge and Ability in Treating Fulminant Myocarditis to Save More Lives
Wang, D. W. (2022) · Springer eBooks · doi:10.1007/978-981-19-5759-8_1
Novel Conceptions in Treatments of Fulminant Myocarditis
Chen, C., Shu, H., & Wang, D. W. (2022) · Springer eBooks · doi:10.1007/978-981-19-5759-8_14
Follow-Up and Long-Term Prognosis of Myocarditis and Fulminant Myocarditis
Jiang, J., & Wang, D. W. (2022) · Springer eBooks · doi:10.1007/978-981-19-5759-8_19
COVID‐19: Cardiology Perspective
DiVita, M. C., CHONDE, M. D., Kamath, M. Y., Vucicevic, D., Fan, A. M., Baas, A. S., & Hsu, J. J. (2022) · Wiley eBooks · doi:10.1002/9781119789741.ch16
Teamwork Makes the Dream Work: Creating Interdisciplinary Synergies Among Cardiothoracic Surgery, Cardiology, Pulmonology, and Anesthesiology
Natanov, R., & Haverich, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-20260-5_6

Authors: Kociol, R. D., Cooper, L. T., Fang, J. C., Moslehi, J. J., Pang, P. S., Sabe, M. A., Shah, R. V., Sims, D. B., Thiene, G., Vardeny, O., & On behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology
ORCID: Kociol, Robb D.
Cooper, Leslie T.
Fang, James C.
Moslehi, Javid J.
Pang, Peter S.
Sabe, Marwa A.
Shah, Ravi V.
Sims, Daniel B.
Thiene, Gaetano
Vardeny, Orly
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2020-02-11
Volume: 141
Issue: 6
Pages: e69-e92
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000000745
OpenAlex: W2999324438
Cited by: 625
References: 199
Citations by year: 2026: 78 · 2025: 69 · 2024: 98 · 2023: 100 · 2022: 121 · 2021: 91 · 2020: 66
FWCI: 58.48
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Mechanical Circulatory Support Devices
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Takotsubo Cardiomyopathy and Associated Phenomena
Keywords: fulminant myocarditis, cardiogenic shock, ventricular arrhythmias, multiple organ failure, mechanical circulatory support, extracorporeal life support, ventricular assist devices, heart transplantation, immunomodulatory therapy, advanced heart failure, delayed diagnosis
MeSH terms: American Heart Association, Arrhythmias, Cardiac, Female, Humans, Multiple Organ Failure, Myocarditis, Shock, Cardiogenic, United States, Extracorporeal Membrane Oxygenation, Heart Transplantation, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks